Alembic Pharmaceuticals Ltd (533573) Stock Price & News

533573:BOM

Alembic Pharmaceuticals Ltd

₹790.50

-0.23%

(-1.80) 1D

Oct 15, 12:22:58 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 533573...

Open

₹793.00

High

₹801.90

Low

₹790.50

Mkt. cap

155.23B

Avg. vol.

21.78K

Volume

7.29K

Dividend

1.52%

Quarterly dividend

₹3.00

Ex-dividend date

Jul 29, 2026

P/E ratio

22.41

52-wk high

₹998.00

52-wk low

₹635.30

EPS

₹35.27

Shares outstanding

188.50M

No. of employees

17K

Open

₹793.00

High

₹801.90

Low

₹790.50

Mkt. cap

155.23B

Avg. vol.

21.78K

Volume

7.29K

Dividend

1.52%

Quarterly dividend

₹3.00

Ex-dividend date

Jul 29, 2026

P/E ratio

22.41

52-wk high

₹998.00

52-wk low

₹635.30

EPS

₹35.27

Shares outstanding

188.50M

No. of employees

17K

News stories

From web sources and news partners

Benzinga

43 minutes ago

Stock Market: Will S&P 500 Open Up or Down Today?

TradingView

3 hours ago

Dow, S&P 500, Nasdaq Decline Amid Hot Inflation Data, AI Selloff: CRWV, NBIS, NVDA, IBRX Stocks In Focus

The Motley Fool

4 hours ago

The S&P 500 Has Risen 30.6% in the First 20 Months of Trump's Second Term, Just Ahead of the 28.5% Gain Over the Same Stretch of His First Term. Here's Why That Comparison Matters for Investors Heading Into the Midterms.

BBN Times

8 hours ago

Dow Jones Today: DJIA Slips to 51,621.48 as UnitedHealth, Merck and Walmart Cushion the Hot CPI Blow

About Alembic Pharmaceuticals Ltd

CEO-

Employees17.2K

Founded1907

Headquarters-

SectorPharmaceutical industry

Website-

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	19.10B	18.76B	18.48B	21.50B
Cost of goods sold	5.16B	5.29B	6.27B	6.20B
Cost of revenue	5.16B	5.29B	6.27B	6.20B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.38B	4.33B	4.39B	4.74B
Operating expense	11.55B	11.34B	10.85B	12.96B
Total operating expenses	16.71B	16.63B	17.11B	19.16B
Operating income	2.40B	2.13B	1.36B	2.34B
Other non operating income	69.00M	154.90M	-285.60M	149.30M
EBT including unusual items	2.24B	1.61B	1.19B	2.22B
EBT excluding unusual items	2.24B	2.04B	1.37B	2.22B
Income tax expense	400.00M	295.40M	-829.00M	495.00M
Effective tax rate	17.88%	18.29%	-69.88%	22.31%
Other operating expenses	6.41B	6.21B	5.56B	7.24B
Net income	1.85B	1.33B	2.03B	1.73B
Net profit margin	9.67%	7.09%	10.97%	8.05%
Earnings per share	9.40	8.51	11.57	8.80
Interest and investment income	-	-	8.60M	-
Interest expense	-242.30M	-233.10M	-225.60M	-276.10M
Net interest expenses	-242.30M	-233.10M	-217.00M	-276.10M
Depreciation and amortization charges	760.70M	801.20M	885.90M	977.10M
EBITDA	3.15B	2.78B	2.12B	3.09B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything